학술논문
Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer
Document Type
Article
Author
Source
In: British Journal of Cancer . (British Journal of Cancer, 3 May 2024, 130(8):1377-1387)
Subject
Language
English
ISSN
15321827
00070920
00070920